首页 > 最新文献

Journal of Infection and Public Health最新文献

英文 中文
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: A 5-year cross-sectional retrospective study and a literature review 育龄妇女 TORCH 感染的血清流行率和与年龄相关的易感性:一项为期 5 年的横断面回顾性研究和文献综述
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-30 DOI: 10.1016/j.jiph.2024.102537
Grazia Pavia , Francesca Licata , Nadia Marascio , Aida Giancotti , Maria Teresa Tassone , Chiara Costa , Giuseppe Guido Maria Scarlata , Licia Elvira Prestagiacomo , Simona Gigliotti , Enrico Maria Trecarichi , Carlo Torti , Aida Bianco , Angela Quirino , Giovanni Matera

Background

Serodiagnosis of TORCH infections should be performed in pre-pregnancy and reproductive-age women to prevent vertical transmission. Herein, we conducted a 5-year cross-sectional retrospective study in childbearing age women to provide prevalence data. Also, stratifying the cohort into three age groups, we identified those most susceptible to acute TORCH infections.

Methods

Between 2019 and 2023, serum samples from 2286 childbearing age women attending the “R. Dulbecco” University Hospital of Catanzaro were collected. Screening for TORCH pathogens, such as: Toxoplasma gondii (TOX), Cytomegalovirus (CMV), Rubella Virus (RUB), Parvovirus B19 (ParvoB19), Herpes Simplex Virus types 1 and 2 (HSV1, HSV2) and Treponema pallidum was carried out using serological tests. Chemiluminescent immunoassay was performed to detect TOX, CMV and ParvoB19 Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies, while Enzyme Linked Fluorescent Assay was performed to detect RUB IgM and IgG antibodies and CMV and TOX IgG Avidity. Enzyme Linked Immunosorbent Assay was performed to detect HSV1 IgG, HSV2 IgG, HSV1/2 IgM, T. pallidum total antibodies and RUB IgG Avidity. Binomial logistic regression models were developed to compare seroprevalence rates among different age groups.

Results

The highest immunological protection was observed for RUB infection (87 %), probably associated with vaccination practice, followed by HSV1 and CMV (82 % and 63 %). The 16–25 year age group results as the most susceptible to acute infections as demonstrated by odds of CMV IgM positivity (primary infection) which decreased with age.

Conclusions

The TORCH serological screening program should be implemented in women before pregnancy to formulate strategies for serological screening of childbearing age women and guiding clinicians in making decisions.

背景为防止垂直传播,应在孕前和育龄妇女中进行 TORCH 感染的筛查诊断。在此,我们对育龄妇女进行了一项为期 5 年的横断面回顾性研究,以提供流行率数据。方法在 2019 年至 2023 年期间,我们收集了 2286 名在卡坦扎罗 "R. Dulbecco "大学医院就诊的育龄妇女的血清样本。筛查 TORCH 病原体,如通过血清学检测对弓形虫 (TOX)、巨细胞病毒 (CMV)、风疹病毒 (RUB)、细小病毒 B19 (ParvoB19)、单纯疱疹病毒 1 型和 2 型 (HSV1 和 HSV2) 以及苍白链球菌进行了筛查。化学发光免疫测定法检测 TOX、CMV 和 ParvoB19 免疫球蛋白 M (IgM) 和免疫球蛋白 G (IgG) 抗体,酶联荧光测定法检测 RUB IgM 和 IgG 抗体以及 CMV 和 TOX IgG 抗体。酶联免疫吸附试验用于检测 HSV1 IgG、HSV2 IgG、HSV1/2 IgM、T. pallidum 总抗体和 RUB IgG 阳性。结果发现,RUB 感染的免疫保护率最高(87%),这可能与疫苗接种有关,其次是 HSV1 和 CMV(82% 和 63%)。结论 TORCH 血清学筛查计划应在孕前妇女中实施,以制定育龄妇女血清学筛查策略并指导临床医生做出决定。
{"title":"Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: A 5-year cross-sectional retrospective study and a literature review","authors":"Grazia Pavia ,&nbsp;Francesca Licata ,&nbsp;Nadia Marascio ,&nbsp;Aida Giancotti ,&nbsp;Maria Teresa Tassone ,&nbsp;Chiara Costa ,&nbsp;Giuseppe Guido Maria Scarlata ,&nbsp;Licia Elvira Prestagiacomo ,&nbsp;Simona Gigliotti ,&nbsp;Enrico Maria Trecarichi ,&nbsp;Carlo Torti ,&nbsp;Aida Bianco ,&nbsp;Angela Quirino ,&nbsp;Giovanni Matera","doi":"10.1016/j.jiph.2024.102537","DOIUrl":"10.1016/j.jiph.2024.102537","url":null,"abstract":"<div><h3>Background</h3><p>Serodiagnosis of TORCH infections should be performed in pre-pregnancy and reproductive-age women to prevent vertical transmission<em>.</em> Herein, we conducted a 5-year cross-sectional retrospective study in childbearing age women to provide prevalence data. Also, stratifying the cohort into three age groups, we identified those most susceptible to acute TORCH infections.</p></div><div><h3>Methods</h3><p>Between 2019 and 2023, serum samples from 2286 childbearing age women attending the “R. Dulbecco” University Hospital of Catanzaro were collected. Screening for TORCH pathogens, such as: <em>Toxoplasma gondii</em> (TOX), Cytomegalovirus (CMV), Rubella Virus (RUB), Parvovirus B19 (ParvoB19), Herpes Simplex Virus types 1 and 2 (HSV1, HSV2) and <em>Treponema pallidum</em> was carried out using serological tests. Chemiluminescent immunoassay was performed to detect TOX, CMV and ParvoB19 Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies, while Enzyme Linked Fluorescent Assay was performed to detect RUB IgM and IgG antibodies and CMV and TOX IgG Avidity. Enzyme Linked Immunosorbent Assay was performed to detect HSV1 IgG, HSV2 IgG, HSV1/2 IgM, <em>T. pallidum</em> total antibodies and RUB IgG Avidity. Binomial logistic regression models were developed to compare seroprevalence rates among different age groups.</p></div><div><h3>Results</h3><p>The highest immunological protection was observed for RUB infection (87 %), probably associated with vaccination practice, followed by HSV1 and CMV (82 % and 63 %). The 16–25 year age group results as the most susceptible to acute infections as demonstrated by odds of CMV IgM positivity (primary infection) which decreased with age.</p></div><div><h3>Conclusions</h3><p>The TORCH serological screening program should be implemented in women before pregnancy to formulate strategies for serological screening of childbearing age women and guiding clinicians in making decisions.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102537"},"PeriodicalIF":4.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002715/pdfft?md5=489d28ffc8036417db733e29d8ffd015&pid=1-s2.0-S1876034124002715-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142161630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fungal-mediated nanoparticles for industrial applications: synthesis and mechanism of action 真菌介导的工业应用纳米颗粒:合成与作用机制
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-30 DOI: 10.1016/j.jiph.2024.102536
Mina Rezghi Rami , Maryam Meskini , Behrouz Ebadi Sharafabad

The advancement of safe, eco-friendly, and cost-efficient techniques for nanoparticle production is a crucial objective in nanotechnology. Among the various sustainable methods, the biological synthesis of nanoparticles utilizing fungi, bacteria, yeasts, and plants stands out. Fungi, in particular, are well suited for this task because of their capacity to secrete numerous enzymes and streamline subsequent processes. Using fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. The utilization of fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. Fungi have long been acknowledged as adept natural engineers capable of creating a wide array of nanoparticles with distinct properties and applications. This article provides an overview of fungus-mediated nanoparticle development, shedding light on the underlying mechanisms of their synthesis and the factors influencing their characteristics. Furthermore, the potential of fungus-mediated nanoparticles in the industrial domain has been explored. These findings emphasize the importance of different fungal species in nanoparticle synthesis, as well as the biocompatibility and environmental friendliness of fungus-mediated nanoparticles. By underscoring the essential role of fungi in connecting natural knowledge with innovative industrial applications, recent progress in enhancing nanoparticle production and optimizing synthesis conditions through fungi has been examined to underscore the feasibility of extensive industrial nanoparticle utilization via fungi.

开发安全、生态友好和具有成本效益的纳米粒子生产技术是纳米技术的一个重要目标。在各种可持续方法中,利用真菌、细菌、酵母菌和植物进行纳米粒子的生物合成最为突出。尤其是真菌,由于其能够分泌多种酶并简化后续过程,因此非常适合这项任务。利用真菌菌株进行纳米粒子生物合成在技术上具有吸引力,在经济上也是可行的。利用真菌菌株进行纳米粒子生物合成在技术上和经济上都是可行的。真菌长期以来一直被认为是能创造出各种具有独特性质和应用的纳米粒子的能干的天然工程师。本文概述了真菌介导的纳米粒子开发,阐明了其合成的基本机制以及影响其特性的因素。此外,还探讨了真菌介导的纳米粒子在工业领域的潜力。这些发现强调了不同真菌种类在纳米粒子合成中的重要性,以及真菌介导的纳米粒子的生物兼容性和环境友好性。通过强调真菌在连接自然知识与创新工业应用方面的重要作用,研究了通过真菌提高纳米粒子生产和优化合成条件的最新进展,以强调通过真菌广泛利用工业纳米粒子的可行性。
{"title":"Fungal-mediated nanoparticles for industrial applications: synthesis and mechanism of action","authors":"Mina Rezghi Rami ,&nbsp;Maryam Meskini ,&nbsp;Behrouz Ebadi Sharafabad","doi":"10.1016/j.jiph.2024.102536","DOIUrl":"10.1016/j.jiph.2024.102536","url":null,"abstract":"<div><p>The advancement of safe, eco-friendly, and cost-efficient techniques for nanoparticle production is a crucial objective in nanotechnology. Among the various sustainable methods, the biological synthesis of nanoparticles utilizing fungi, bacteria, yeasts, and plants stands out. Fungi, in particular, are well suited for this task because of their capacity to secrete numerous enzymes and streamline subsequent processes. Using fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. The utilization of fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. Fungi have long been acknowledged as adept natural engineers capable of creating a wide array of nanoparticles with distinct properties and applications. This article provides an overview of fungus-mediated nanoparticle development, shedding light on the underlying mechanisms of their synthesis and the factors influencing their characteristics. Furthermore, the potential of fungus-mediated nanoparticles in the industrial domain has been explored. These findings emphasize the importance of different fungal species in nanoparticle synthesis, as well as the biocompatibility and environmental friendliness of fungus-mediated nanoparticles. By underscoring the essential role of fungi in connecting natural knowledge with innovative industrial applications, recent progress in enhancing nanoparticle production and optimizing synthesis conditions through fungi has been examined to underscore the feasibility of extensive industrial nanoparticle utilization via fungi.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102536"},"PeriodicalIF":4.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002703/pdfft?md5=d4f325456973acbf9e35c2ba6c294961&pid=1-s2.0-S1876034124002703-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142172943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gram-negative bacterial colonization in the gut: Isolation, characterization, and identification of resistance mechanisms 革兰氏阴性菌在肠道中的定植:耐药性机制的分离、表征和鉴定
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-30 DOI: 10.1016/j.jiph.2024.102535
Yara Khachab, Said El Shamieh, Elie Salem Sokhn

Background

The gut microbiome is made up of a diverse range of bacteria, especially gram-negative bacteria, and is crucial for human health and illness. There is a great deal of interest in the dynamic interactions between gram-negative bacteria and their host environment, especially considering antibiotic resistance. This work aims to isolate gram-negative bacteria that exist in the gut, identify their species, and use resistance-associated gene analysis to define their resistance mechanisms.

Methods

Samples were collected from all patients who had a stool culture at a tertiary care center in Lebanon. Each type of bacteria that was identified from the stool samples was subjected to critical evaluations, and all discovered strains underwent antimicrobial susceptibility testing. Polymerase chain reaction was used to profile the genes for Carbapenem-resistant Enterobacteriaceae (CRE), Extended-spectrum beta-lactamase (ESBL), and that of Pseudomonas aeruginosa strains.

Results

Escherichia coli, Klebsiella species, and Pseudomonas aeruginosa turned out to be the predominant microbiota members. Escherichia coli strains had a high frequency of extended-spectrum beta-lactamase genes, with the most discovered gene being bla CTX-M. Additionally, a considerable percentage of isolates had carbapenemase-resistant Enterobacteriaceae genes, suggesting the rise of multidrug-resistant strains. Multidrug resistance genes, such as bla mexR, bla mexB, and bla mexA, were found in strains of Pseudomonas aeruginosa, highlighting the possible difficulties in treating infections brought on by these bacteria.

Conclusion

The findings highlight the critical importance of effective surveillance and response measures to maintain the effectiveness of antibiotics considering the introduction of multidrug resistance genes in Pseudomonas aeruginosa and ESBL and CRE genes in Escherichia coli.

背景肠道微生物组由多种细菌组成,尤其是革兰氏阴性菌,对人类健康和疾病至关重要。人们对革兰氏阴性细菌与其宿主环境之间的动态相互作用非常感兴趣,特别是考虑到抗生素的耐药性。这项研究旨在分离存在于肠道中的革兰氏阴性细菌,确定其种类,并利用耐药性相关基因分析确定其耐药性机制。对从粪便样本中鉴定出的每种细菌都进行了严格的评估,并对所有发现的菌株进行了抗菌药敏感性测试。聚合酶链反应用于分析耐碳青霉烯类肠杆菌科细菌(CRE)、广谱β-内酰胺酶(ESBL)和铜绿假单胞菌菌株的基因。大肠埃希菌菌株含有高频率的广谱β-内酰胺酶基因,其中发现最多的基因是 bla CTX-M。此外,相当大比例的分离菌株带有耐碳青霉烯酶的肠杆菌科细菌基因,这表明耐多药菌株正在增加。在铜绿假单胞菌菌株中发现了 bla mexR、bla mexB 和 bla mexA 等耐多药基因,凸显了治疗由这些细菌引起的感染可能存在的困难。
{"title":"Gram-negative bacterial colonization in the gut: Isolation, characterization, and identification of resistance mechanisms","authors":"Yara Khachab,&nbsp;Said El Shamieh,&nbsp;Elie Salem Sokhn","doi":"10.1016/j.jiph.2024.102535","DOIUrl":"10.1016/j.jiph.2024.102535","url":null,"abstract":"<div><h3>Background</h3><p>The gut microbiome is made up of a diverse range of bacteria, especially gram-negative bacteria, and is crucial for human health and illness. There is a great deal of interest in the dynamic interactions between gram-negative bacteria and their host environment, especially considering antibiotic resistance. This work aims to isolate gram-negative bacteria that exist in the gut, identify their species, and use resistance-associated gene analysis to define their resistance mechanisms.</p></div><div><h3>Methods</h3><p>Samples were collected from all patients who had a stool culture at a tertiary care center in Lebanon. Each type of bacteria that was identified from the stool samples was subjected to critical evaluations, and all discovered strains underwent antimicrobial susceptibility testing. Polymerase chain reaction was used to profile the genes for Carbapenem-resistant <em>Enterobacteriaceae</em> (CRE), Extended-spectrum beta-lactamase (ESBL), and that of <em>Pseudomonas aeruginosa</em> strains.</p></div><div><h3>Results</h3><p><em>Escherichia coli</em>, <em>Klebsiella</em> species, and <em>Pseudomonas aeruginosa</em> turned out to be the predominant microbiota members. <em>Escherichia coli</em> strains had a high frequency of extended-spectrum beta-lactamase genes, with the most discovered gene being <em>bla</em> CTX-M. Additionally, a considerable percentage of isolates had carbapenemase-resistant <em>Enterobacteriaceae</em> genes, suggesting the rise of multidrug-resistant strains. Multidrug resistance genes, such as <em>bla</em> mexR, <em>bla</em> mexB, and <em>bla</em> mexA, were found in strains of <em>Pseudomonas aeruginosa</em>, highlighting the possible difficulties in treating infections brought on by these bacteria.</p></div><div><h3>Conclusion</h3><p>The findings highlight the critical importance of effective surveillance and response measures to maintain the effectiveness of antibiotics considering the introduction of multidrug resistance genes in <em>Pseudomonas aeruginosa</em> and ESBL and CRE genes in <em>Escherichia coli</em>.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102535"},"PeriodicalIF":4.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002697/pdfft?md5=4c3fb3a611e49e16488e951b01af72b4&pid=1-s2.0-S1876034124002697-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142094964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality and morbidity in critically ill COVID-19 patients: A systematic review and meta-analysis COVID-19 重症患者的死亡率和发病率:系统回顾和荟萃分析。
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-29 DOI: 10.1016/j.jiph.2024.102533
Gebreamlak Gebremedhn Gebremeskel , Degena Bahrey Tadesse , Teklehaimanot Gereziher Haile

Background

The COVID-19 pandemic has caused 14.83 million deaths globally. This systematic review and meta-analysis aimed to provide a pooled estimate of the overall mortality and morbidity of critically ill COVID-19 patients.

Method

Four electronic databases, Medline/PubMed, the Cochrane Library, the WHO COVID-19 database, and the Web of Science, were used to identify relevant studies. Two authors independently screened the studies, evaluated the eligibility criteria and resolved discrepancies through discussion with the third author. The pooled effect size was computed using STATA software version 14. The Cochran Q test and I2 test were utilized to assess heterogeneity across the studies. Additionally, subgroup analysis, sensitivity analysis, and publication bias were evaluated. It is registered in Prospero with Prospero ID CRD42020212146.

Results

A total of 1003 published articles were screened from various databases, and 24 studies involving a total of 142,291 critically ill COVID-19 participants were selected for inclusion in the review. Among the participants, 67 % were male, and the mean age was 63.43 + SD3.33 years. The mortality rate reported in the individual studies ranged from 4.5 % to 69.5 %. The findings from the analysis revealed that the overall pooled mortality rate was 34 % (95 % confidence interval: 31 %−37 %). Additionally, the findings showed that 62 % of critically ill COVID-19 patients required mechanical ventilation, while 68.7 % of these patients had chronic disease comorbidities.

Conclusion

Critically ill COVID-19 patients face a high-risk risk of death, with an estimate of about one in three patients dying from the virus. Notably, a substantial portion of critically ill COVID-19 patients (62 %) require mechanical ventilation; surprisingly, more than two-thirds of patients with COVID-19 have chronic disease comorbidities, highlighting the importance of managing comorbidities in this population.

背景:COVID-19大流行已造成全球1 483万人死亡。本系统综述和荟萃分析旨在对 COVID-19 重症患者的总体死亡率和发病率进行综合估计:方法:使用 Medline/PubMed、Cochrane 图书馆、WHO COVID-19 数据库和 Web of Science 四个电子数据库来确定相关研究。两位作者独立筛选研究,评估资格标准,并通过与第三位作者讨论解决差异。汇总效应大小使用 STATA 软件 14 版计算。Cochran Q 检验和 I2 检验用于评估各研究之间的异质性。此外,还对亚组分析、敏感性分析和发表偏倚进行了评估。该研究已在 Prospero 注册,Prospero ID 为 CRD42020212146:从各种数据库中共筛选出 1003 篇已发表的文章,其中有 24 项研究被纳入综述,共涉及 142291 名 COVID-19 重症患者。其中男性占 67%,平均年龄为 63.43 + SD3.33 岁。各项研究报告的死亡率从 4.5% 到 69.5% 不等。分析结果显示,总死亡率为 34%(95% 置信区间:31%-37%)。此外,研究结果显示,COVID-19 重症患者中有 62% 需要机械通气,其中 68.7% 有慢性疾病合并症:结论:COVID-19 重症患者面临着很高的死亡风险,估计每三名患者中就有一人死于该病毒。值得注意的是,相当一部分 COVID-19 重症患者(62%)需要进行机械通气;令人惊讶的是,超过三分之二的 COVID-19 患者患有慢性疾病合并症,这凸显了控制这类人群合并症的重要性。
{"title":"Mortality and morbidity in critically ill COVID-19 patients: A systematic review and meta-analysis","authors":"Gebreamlak Gebremedhn Gebremeskel ,&nbsp;Degena Bahrey Tadesse ,&nbsp;Teklehaimanot Gereziher Haile","doi":"10.1016/j.jiph.2024.102533","DOIUrl":"10.1016/j.jiph.2024.102533","url":null,"abstract":"<div><h3>Background</h3><p>The COVID-19 pandemic has caused 14.83 million deaths globally. This systematic review and meta-analysis aimed to provide a pooled estimate of the overall mortality and morbidity of critically ill COVID-19 patients.</p></div><div><h3>Method</h3><p>Four electronic databases, Medline/PubMed, the Cochrane Library, the WHO COVID-19 database, and the Web of Science, were used to identify relevant studies. Two authors independently screened the studies, evaluated the eligibility criteria and resolved discrepancies through discussion with the third author. The pooled effect size was computed using STATA software version 14. The Cochran Q test and I<sup>2</sup> test were utilized to assess heterogeneity across the studies. Additionally, subgroup analysis, sensitivity analysis, and publication bias were evaluated. It is registered in Prospero with Prospero ID CRD42020212146.</p></div><div><h3>Results</h3><p>A total of 1003 published articles were screened from various databases, and 24 studies involving a total of 142,291 critically ill COVID-19 participants were selected for inclusion in the review. Among the participants, 67 % were male, and the mean age was 63.43 <u>+</u> SD3.33 years. The mortality rate reported in the individual studies ranged from 4.5 % to 69.5 %. The findings from the analysis revealed that the overall pooled mortality rate was 34 % (95 % confidence interval: 31 %−37 %). Additionally, the findings showed that 62 % of critically ill COVID-19 patients required mechanical ventilation, while 68.7 % of these patients had chronic disease comorbidities.</p></div><div><h3>Conclusion</h3><p>Critically ill COVID-19 patients face a high-risk risk of death, with an estimate of about one in three patients dying from the virus. Notably, a substantial portion of critically ill COVID-19 patients (62 %) require mechanical ventilation; surprisingly, more than two-thirds of patients with COVID-19 have chronic disease comorbidities, highlighting the importance of managing comorbidities in this population.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102533"},"PeriodicalIF":4.7,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002673/pdfft?md5=55d59fdeff1dadc850a906824f526410&pid=1-s2.0-S1876034124002673-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seasonal variations of empyema in Taiwan: A 10-year analysis 台湾肺水肿的季节性变化:十年分析
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-28 DOI: 10.1016/j.jiph.2024.102534
Ya-Fu Cheng , Yi-Ling Chen , Wan-Ling Chuang , Chia-Che Chang , Bing-Yen Wang

Background

Empyema is a serious infection in pleural space. Finding out seasonal variations of empyema and its pathogens can help in providing preventive measures, and implicating future researches.

Methods

This study is a 10-year observational study in a single center. Patients with empyema thoracis receiving thoracoscopic decortication between January 2012 and December 2021 were included in the study.

Results

There were 1082 empyema patients enrolled in this study. No seasonal variation was noted (spring = 25.7 %, summer =25.5 %, autumn = 24.8 %, winter = 24.0 %). However, we observed seasonal variations in pathogens. Streptococcus species had slightly higher prevalence in winter and spring than summer and autumn (54.3 % vs. 45.7 %) without significant difference (p = 0.251). On the contrary, Staphylococcus species occurred more often in summer and autumn than winter and spring (61.5 % vs. 38.5 %) (p = 0.035). Klebsiella species were more likely found in autumn (34.9 %) (p = 0.050), and Pseudomonas species showed no peak prevalence in any season (p = 0.423). The incidence of Streptococcus species increased over the years.

Conclusions

Although no seasonal variation was found in severe empyema patients requiring surgery, there were seasonal variations for the pathogens in Taiwan. The medical community should focus on Streptococcus species in winter and spring and Staphylococcus species in summer and autumn.

背景肺水肿是一种严重的胸膜腔感染。发现肺水肿及其病原体的季节性变化有助于提供预防措施,并对未来研究产生影响。研究纳入了 2012 年 1 月至 2021 年 12 月期间接受胸腔镜去脓肿术的胸腔积液患者。没有发现季节性变化(春季=25.7%,夏季=25.5%,秋季=24.8%,冬季=24.0%)。不过,我们观察到了病原体的季节性变化。链球菌在冬季和春季的感染率略高于夏季和秋季(54.3 % 对 45.7 %),但无明显差异(p = 0.251)。相反,葡萄球菌在夏秋季比冬春季更常见(61.5% 对 38.5%)(p = 0.035)。克雷伯菌更多出现在秋季(34.9%)(p = 0.050),假单胞菌在任何季节都没有出现流行高峰(p = 0.423)。结论虽然在需要手术的严重肺水肿患者中未发现季节性变化,但台湾的病原体存在季节性变化。医学界应重点关注冬春季的链球菌和夏秋季的葡萄球菌。
{"title":"Seasonal variations of empyema in Taiwan: A 10-year analysis","authors":"Ya-Fu Cheng ,&nbsp;Yi-Ling Chen ,&nbsp;Wan-Ling Chuang ,&nbsp;Chia-Che Chang ,&nbsp;Bing-Yen Wang","doi":"10.1016/j.jiph.2024.102534","DOIUrl":"10.1016/j.jiph.2024.102534","url":null,"abstract":"<div><h3>Background</h3><p>Empyema is a serious infection in pleural space. Finding out seasonal variations of empyema and its pathogens can help in providing preventive measures, and implicating future researches.</p></div><div><h3>Methods</h3><p>This study is a 10-year observational study in a single center. Patients with empyema thoracis receiving thoracoscopic decortication between January 2012 and December 2021 were included in the study.</p></div><div><h3>Results</h3><p>There were 1082 empyema patients enrolled in this study. No seasonal variation was noted (spring = 25.7 %, summer =25.5 %, autumn = 24.8 %, winter = 24.0 %). However, we observed seasonal variations in pathogens. <em>Streptococcus</em> species had slightly higher prevalence in winter and spring than summer and autumn (54.3 % vs. 45.7 %) without significant difference (p = 0.251). On the contrary, <em>Staphylococcus</em> species occurred more often in summer and autumn than winter and spring (61.5 % vs. 38.5 %) (p = 0.035). <em>Klebsiella</em> species were more likely found in autumn (34.9 %) (p = 0.050), and <em>Pseudomonas</em> species showed no peak prevalence in any season (p = 0.423). The incidence of <em>Streptococcus</em> species increased over the years.</p></div><div><h3>Conclusions</h3><p>Although no seasonal variation was found in severe empyema patients requiring surgery, there were seasonal variations for the pathogens in Taiwan. The medical community should focus on <em>Streptococcus</em> species in winter and spring and <em>Staphylococcus</em> species in summer and autumn.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102534"},"PeriodicalIF":4.7,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002685/pdfft?md5=8a192b7d856d59fc791ef33d04b33c8e&pid=1-s2.0-S1876034124002685-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142095071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human papillomavirus vaccination and Pap test uptake, awareness, and barriers among young adults in Gulf Cooperation Council countries: A comparative cross-sectional survey 海湾合作委员会国家年轻成年人对人类乳头瘤病毒疫苗接种和巴氏试验的接受、认识和障碍:一项横断面比较调查。
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-28 DOI: 10.1016/j.jiph.2024.102525
Ibrahim Mahmoud , Mithaq Mohammed A Al Eid , Meera Ahmed Mohamed , Ahmad Jehad Aladwani , Nagwa El Mustafa El Amin

Background

Human papillomavirus (HPV) vaccination and Pap tests are recognized as effective preventive measures to reduce the incidence of HPV-related diseases among young adults. The objective of this study was to assess HPV vaccination and Pap test uptake, awareness, and barriers among young adults in the Gulf Cooperation Council (GCC) countries, including Bahrain, Kuwait, Oman, Qatar, the Kingdom of Saudi Arabia (KSA), and the United Arab Emirates (UAE).

Methods

A comparative cross-sectional study was conducted from January to April 2024, involving 831 young adults aged 18–39 residing in GCC countries. The main outcome measures were HPV vaccination and Pap test uptake rates, awareness of the HPV vaccine and Pap testing, and barriers to vaccination. Data were collected using online platforms. The Chi-square test and Fisher’s exact test were used for data analysis.

Results

The UAE had the highest vaccination rate at 18.9% (50/264), followed by Qatar at 5.8% (6/104), and KSA at 4.6% (10/216), p < 0.001. Individuals with health insurance had higher vaccination rates than those without (11% vs. 5.4%, p = 0.006). Awareness of the HPV vaccine was highest in the UAE (49.6%) and KSA (58.8%), while awareness of Pap smear testing among females was similarly high in these countries (62.4% and 65.9%, respectively). However, actual Pap smear testing rates were highest in Bahrain (15.9%) and Qatar (13.4%). The main barriers to vaccination cited by participants were lack of knowledge (53.6%) and the absence of medical recommendations (13.2%).

Conclusion

The study's findings suggest the need of targeted educational campaigns to increase HPV vaccine uptake among both genders and Pap test participation among females. Additionally, incorporating HPV screening and vaccination into routine national programs in GCC countries and emphasising the crucial role of healthcare providers in influencing vaccination decisions are recommended strategies.

背景:人类乳头瘤病毒(HPV)疫苗接种和巴氏试验被认为是降低青壮年 HPV 相关疾病发病率的有效预防措施。本研究旨在评估海湾合作委员会(GCC)国家(包括巴林、科威特、阿曼、卡塔尔、沙特阿拉伯王国(KSA)和阿拉伯联合酋长国(UAE))青壮年对 HPV 疫苗接种和巴氏试验的接受程度、认识和障碍:方法:在 2024 年 1 月至 4 月期间进行了一项横断面比较研究,涉及居住在海湾合作委员会国家的 831 名 18-39 岁的年轻人。主要结果指标包括:HPV 疫苗接种率和巴氏试验接受率、对 HPV 疫苗和巴氏试验的了解程度以及接种疫苗的障碍。数据通过在线平台收集。数据分析采用卡方检验(Chi-square test)和费雪精确检验(Fisher's exact test):结果:阿联酋的疫苗接种率最高,为 18.9%(50/264),其次是卡塔尔的 5.8%(6/104)和沙特的 4.6%(10/216):研究结果表明,有必要开展有针对性的教育活动,以提高女性和男性的 HPV 疫苗接种率和巴氏试验参与率。此外,将 HPV 筛查和疫苗接种纳入海湾合作委员会国家的常规国家计划,并强调医疗服务提供者在影响疫苗接种决定方面的关键作用,也是值得推荐的策略。
{"title":"Human papillomavirus vaccination and Pap test uptake, awareness, and barriers among young adults in Gulf Cooperation Council countries: A comparative cross-sectional survey","authors":"Ibrahim Mahmoud ,&nbsp;Mithaq Mohammed A Al Eid ,&nbsp;Meera Ahmed Mohamed ,&nbsp;Ahmad Jehad Aladwani ,&nbsp;Nagwa El Mustafa El Amin","doi":"10.1016/j.jiph.2024.102525","DOIUrl":"10.1016/j.jiph.2024.102525","url":null,"abstract":"<div><h3>Background</h3><p>Human papillomavirus (HPV) vaccination and Pap tests are recognized as effective preventive measures to reduce the incidence of HPV-related diseases among young adults. The objective of this study was to assess HPV vaccination and Pap test uptake, awareness, and barriers among young adults in the Gulf Cooperation Council (GCC) countries, including Bahrain, Kuwait, Oman, Qatar, the Kingdom of Saudi Arabia (KSA), and the United Arab Emirates (UAE).</p></div><div><h3>Methods</h3><p>A comparative cross-sectional study was conducted from January to April 2024, involving 831 young adults aged 18–39 residing in GCC countries. The main outcome measures were HPV vaccination and Pap test uptake rates, awareness of the HPV vaccine and Pap testing, and barriers to vaccination. Data were collected using online platforms. The Chi-square test and Fisher’s exact test were used for data analysis.</p></div><div><h3>Results</h3><p>The UAE had the highest vaccination rate at 18.9% (50/264), followed by Qatar at 5.8% (6/104), and KSA at 4.6% (10/216), p &lt; 0.001. Individuals with health insurance had higher vaccination rates than those without (11% vs. 5.4%, p = 0.006). Awareness of the HPV vaccine was highest in the UAE (49.6%) and KSA (58.8%), while awareness of Pap smear testing among females was similarly high in these countries (62.4% and 65.9%, respectively). However, actual Pap smear testing rates were highest in Bahrain (15.9%) and Qatar (13.4%). The main barriers to vaccination cited by participants were lack of knowledge (53.6%) and the absence of medical recommendations (13.2%).</p></div><div><h3>Conclusion</h3><p>The study's findings suggest the need of targeted educational campaigns to increase HPV vaccine uptake among both genders and Pap test participation among females. Additionally, incorporating HPV screening and vaccination into routine national programs in GCC countries and emphasising the crucial role of healthcare providers in influencing vaccination decisions are recommended strategies<strong>.</strong></p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102525"},"PeriodicalIF":4.7,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002594/pdfft?md5=b73088d3c00a0768732a24e8a9721d5f&pid=1-s2.0-S1876034124002594-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis HCV相关Child-Pugh B级肝硬化患者血液微生物组的改变。
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-27 DOI: 10.1016/j.jiph.2024.102524
Oscar Brochado-Kith , Marta Rava , Juan Berenguer , Juan González-García , David Rojo , Cristina Díez , Victor Hontañon , Ana Virseda-Berdices , Luis Ibañez-Samaniego , Elba Llop-Herrera , Antonio Olveira , Leire Pérez-Latorre , Coral Barbas , Amanda Fernández-Rodríguez , Salvador Resino , María Angeles Jiménez-Sousa , the Escorial Study Group

Background

Altered bacterial translocation is associated with changes in hepatic function and the progression from compensated to decompensated cirrhosis. Child-Turcotte-Pugh (CTP) score is an essential indicator of liver severity. Thus, we aimed to study differences in the blood microbiome together with metabolome profile between HCV-infected patients with CTP class B (CTP-B, significant functional compromise) and patients with CTP class A (CTP-A, well-compensated cirrhosis).

Methods

We conducted a cross-sectional study in patients with advanced HCV-related cirrhosis (n = 88) stratified by CTP-B and CTP-A. Bacterial 16S rRNA sequencing was sequenced by MiSeq Illumina technology and non-targeted metabolomics was performed by GC-MS and LC-MS ESI+ and ESI- to complement the analysis.

Results

Patients with CTP-B had lower levels of richness (Chao1), and alpha diversity (Shannon and Simpson indexes) at phylum level than patients with CTP-A. Likewise, we observed significant differences in beta diversity between groups at phylum, class, and order levels, showing lower diversity in patients with CTP-B. Higher relative abundance of Proteobacteria (p = 0.012), Alphaproteobacteria (p = 0.005), Sphingomonadales (p = 0.012) and Sphingomonadaceae (p = 0.016) were significantly associated with CTP-B. The phylum Proteobacteria was positively correlated with ethanolamine and oleic acid (p = 0.005 and p = 0.004, respectively) and negatively with p-cresol (p = 0.006). In addition, the order Sphingomonadales and the family Sphingomonadaceae was also negatively correlated with p-cresol (p = 0.001 and p = 0.001).

Conclusions

Blood microbial diversity was significantly decreased in patients with CTP-B, who presented an enrichment of Proteobacteria, Alphaproteobacteria, Sphingomonadales and Sphingomonadaceae compared to patients with CTP-A.

背景:细菌转位的改变与肝功能的变化以及从代偿性肝硬化发展为失代偿性肝硬化有关。Child-Turcotte-Pugh(CTP)评分是衡量肝脏严重程度的重要指标。因此,我们旨在研究 CTP B 级(CTP-B,功能严重受损)和 CTP A 级(CTP-A,肝硬化代偿良好)HCV 感染者血液微生物组和代谢组谱的差异:我们对晚期 HCV 相关性肝硬化患者(88 人)进行了一项横断面研究,按照 CTP-B 和 CTP-A 进行了分层。采用 MiSeq Illumina 技术进行了细菌 16S rRNA 测序,并通过 GC-MS 和 LC-MS ESI+ 和 ESI- 进行了非靶向代谢组学分析:结果:与CTP-A患者相比,CTP-B患者在门一级的丰富度(Chao1)和α多样性(香农指数和辛普森指数)水平较低。同样,我们观察到不同组别之间在门、类和目层次上的β多样性存在显著差异,显示CTP-B患者的多样性较低。蛋白细菌(p = 0.012)、表蛋白细菌(p = 0.005)、鞘氨单胞菌(p = 0.012)和鞘氨单胞菌科(p = 0.016)的相对丰度较高与 CTP-B 显著相关。蛋白菌门与乙醇胺和油酸呈正相关(分别为 p = 0.005 和 p = 0.004),与对甲酚呈负相关(p = 0.006)。此外,鞘氨单胞菌目和鞘氨单胞菌科也与对甲酚呈负相关(p = 0.001 和 p = 0.001):结论:与CTP-A患者相比,CTP-B患者血液中的微生物多样性明显降低,蛋白质细菌、低等蛋白质细菌、鞘氨单胞菌纲和鞘氨单胞菌科的数量增多。
{"title":"Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis","authors":"Oscar Brochado-Kith ,&nbsp;Marta Rava ,&nbsp;Juan Berenguer ,&nbsp;Juan González-García ,&nbsp;David Rojo ,&nbsp;Cristina Díez ,&nbsp;Victor Hontañon ,&nbsp;Ana Virseda-Berdices ,&nbsp;Luis Ibañez-Samaniego ,&nbsp;Elba Llop-Herrera ,&nbsp;Antonio Olveira ,&nbsp;Leire Pérez-Latorre ,&nbsp;Coral Barbas ,&nbsp;Amanda Fernández-Rodríguez ,&nbsp;Salvador Resino ,&nbsp;María Angeles Jiménez-Sousa ,&nbsp;the Escorial Study Group","doi":"10.1016/j.jiph.2024.102524","DOIUrl":"10.1016/j.jiph.2024.102524","url":null,"abstract":"<div><h3>Background</h3><p>Altered bacterial translocation is associated with changes in hepatic function and the progression from compensated to decompensated cirrhosis. Child-Turcotte-Pugh (CTP) score is an essential indicator of liver severity. Thus, we aimed to study differences in the blood microbiome together with metabolome profile between HCV-infected patients with CTP class B (CTP-B, significant functional compromise) and patients with CTP class A (CTP-A, well-compensated cirrhosis).</p></div><div><h3>Methods</h3><p>We conducted a cross-sectional study in patients with advanced HCV-related cirrhosis (n = 88) stratified by CTP-B and CTP-A. Bacterial 16S rRNA sequencing was sequenced by MiSeq Illumina technology and non-targeted metabolomics was performed by GC-MS and LC-MS ESI+ and ESI- to complement the analysis.</p></div><div><h3>Results</h3><p>Patients with CTP-B had lower levels of richness (Chao1), and alpha diversity (Shannon and Simpson indexes) at phylum level than patients with CTP-A. Likewise, we observed significant differences in beta diversity between groups at phylum, class, and order levels, showing lower diversity in patients with CTP-B. Higher relative abundance of Proteobacteria (p = 0.012), Alphaproteobacteria (p = 0.005), Sphingomonadales (p = 0.012) and <em>Sphingomonadaceae</em> (p = 0.016) were significantly associated with CTP-B. The phylum Proteobacteria was positively correlated with ethanolamine and oleic acid (p = 0.005 and p = 0.004, respectively) and negatively with p-cresol (p = 0.006). In addition, the order Sphingomonadales and the family <em>Sphingomonadaceae</em> was also negatively correlated with p-cresol (p = 0.001 and p = 0.001).</p></div><div><h3>Conclusions</h3><p>Blood microbial diversity was significantly decreased in patients with CTP-B, who presented an enrichment of Proteobacteria, Alphaproteobacteria, Sphingomonadales and <em>Sphingomonadaceae</em> compared to patients with CTP-A.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102524"},"PeriodicalIF":4.7,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002582/pdfft?md5=f651de7eb8cb53762cbda610f149d1d5&pid=1-s2.0-S1876034124002582-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report 使用尼马瑞韦/利托那韦延长疗程治疗 B 细胞急性淋巴细胞白血病患者的 2019 年冠状病毒病(COVID-19)顽症:病例报告
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-24 DOI: 10.1016/j.jiph.2024.102526
Hassan Almarhabi , Aisha Alharbi , Mai Alalawi , Mohamed Firoze Ahamed , Ihab El-Hemaidi , Nader Damfu

Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.

血液恶性肿瘤患者感染冠状病毒2019病(COVID-19)的风险增加,这是一种独特的临床症状,其最佳治疗方法尚不清楚。在此,我们报告了一例急性淋巴细胞白血病(ALL)患者的持续性COVID-19感染病例,该患者对延长疗程的尼马瑞韦/利托那韦治疗成功应答。
{"title":"Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report","authors":"Hassan Almarhabi ,&nbsp;Aisha Alharbi ,&nbsp;Mai Alalawi ,&nbsp;Mohamed Firoze Ahamed ,&nbsp;Ihab El-Hemaidi ,&nbsp;Nader Damfu","doi":"10.1016/j.jiph.2024.102526","DOIUrl":"10.1016/j.jiph.2024.102526","url":null,"abstract":"<div><p>Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102526"},"PeriodicalIF":4.7,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002600/pdfft?md5=8d0f1d131b44d5a68a71b6bfefdd8049&pid=1-s2.0-S1876034124002600-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142122516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt 重症监护环境中的COVID-19后粘孢子菌病:埃及一家三级护理中心的前瞻性队列研究
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-22 DOI: 10.1016/j.jiph.2024.102523
Nahawand A. EL-Deeb , Shaherah Yousef Andargeery , Hanaa A. Nofal , Dina S. Elrafey , Ebthall Mohamed , Nevin F. Ibrahim , Hossam Tharwat Ali , Ayman M.E.M. Sadek

Background

The emergence of mucormycosis as a life-threatening fungal infection after the coronavirus disease of 2019 (COVID-19) is a major concern and challenge, but there is limited information on the risk factors for mortality in patients.

Methods

We conducted a prospective cohort study from May 2021 to April 2022 to determine the in-hospital outcomes of post-COVID-19 mucormycosis during the intensive care unit (ICU) stay. The sample of the study was collected as consecutive sampling using all accessible patients in the study period. The Statistical Package for Social Sciences (SPSS), version 25 (IBM, Chicago, Illinois, USA) was used for statistical analysis.

Results

Among 150 patients with post-COVID-19 mucormycosis, the majority had a primary sinus infection (86.0 %), while 11.3 % had both sinus and ocular infections, and 2.7 % had sinus and cutaneous infections. Around 21 % (n = 31) of patients deceased after staying in the ICU for a median (range) of 45.0 (10.0–145.0) days. The majority of the patients who deceased had pneumonia patches on computed tomography (CT) (90.3 %) while none of the patients who were discharged had pneumonia patches (p < 0.001). The deceased group had higher rates of pulmonary embolism (93.5 %) compared to the surviving groups (21.8 %). In a multivariate Cox regression analysis, the risk of death was higher in older patients above 60 years old (hazard ratio (95 %CI): 6.7 (1.73–15.81)), increase among patient with history of steroid administration (hazard ratio (95 %CI): 5.70 (1.23–10.91)), who had facial cutaneous infection with mucormycosis (hazard ratio (95 %CI): 8.76 (1.78–25.18)), patients with uncontrolled diabetes (hazard ratio (95 %CI): 10.76 (1.78, 65.18)), and total leukocytic count (TLC>10 ×103 mcL) (hazard ratio (95 %CI): 10.03 (3.29–30.61)).

Conclusions

Identifying high-risk patients especially old diabetic patients with corticosteroid administration and detecting their deterioration quickly is crucial in reducing post-COVID-19 mucormycosis mortality rates, and these factors must be considered when developing treatment and quarantine strategies.

背景在2019年冠状病毒病(COVID-19)之后,粘孢子菌病作为一种威胁生命的真菌感染而出现,这是一个值得关注的重大问题和挑战,但有关患者死亡风险因素的信息却很有限。方法我们在2021年5月至2022年4月期间开展了一项前瞻性队列研究,以确定COVID-19后粘孢子菌病患者在重症监护病房(ICU)住院期间的院内结局。研究样本采用连续抽样的方式,收集研究期间所有可接触到的患者。结果在150名COVID-19后粘孢子菌病患者中,大多数人患有原发性鼻窦感染(86.0%),11.3%的人同时患有鼻窦和眼部感染,2.7%的人患有鼻窦和皮肤感染。约 21% 的患者(n = 31)在重症监护病房住院中位数(范围)为 45.0(10.0-145.0)天后死亡。大多数死亡患者的计算机断层扫描(CT)结果显示有肺炎斑块(90.3%),而出院患者中没有人有肺炎斑块(p < 0.001)。与存活组(21.8%)相比,死亡组的肺栓塞发生率更高(93.5%)。在多变量 Cox 回归分析中,60 岁以上的老年患者死亡风险更高(危险比(95 %CI):6.7(1.73-15.81)),有类固醇用药史的患者死亡风险更高(危险比(95 %CI):5.70(1.23-10.91))、面部皮肤感染粘孢子虫病(危险比(95 %CI):8.76(1.78-25.18))、糖尿病未得到控制的患者(危险比(95 %CI):10.76(1.78,65.18))和白细胞总数(TLC>10 ×103 mcL)(危险比(95 %CI):10.03(3.29-30.61))。结论识别高危患者,尤其是使用皮质类固醇的老年糖尿病患者,并迅速发现他们的病情恶化,对于降低COVID-19后的粘孢子虫病死率至关重要,在制定治疗和检疫策略时必须考虑这些因素。
{"title":"Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt","authors":"Nahawand A. EL-Deeb ,&nbsp;Shaherah Yousef Andargeery ,&nbsp;Hanaa A. Nofal ,&nbsp;Dina S. Elrafey ,&nbsp;Ebthall Mohamed ,&nbsp;Nevin F. Ibrahim ,&nbsp;Hossam Tharwat Ali ,&nbsp;Ayman M.E.M. Sadek","doi":"10.1016/j.jiph.2024.102523","DOIUrl":"10.1016/j.jiph.2024.102523","url":null,"abstract":"<div><h3>Background</h3><p>The emergence of mucormycosis as a life-threatening fungal infection after the coronavirus disease of 2019 (COVID-19) is a major concern and challenge, but there is limited information on the risk factors for mortality in patients.</p></div><div><h3>Methods</h3><p>We conducted a prospective cohort study from May 2021 to April 2022 to determine the in-hospital outcomes of post-COVID-19 mucormycosis during the intensive care unit (ICU) stay. The sample of the study was collected as consecutive sampling using all accessible patients in the study period. The Statistical Package for Social Sciences (SPSS), version 25 (IBM, Chicago, Illinois, USA) was used for statistical analysis.</p></div><div><h3>Results</h3><p>Among 150 patients with post-COVID-19 mucormycosis, the majority had a primary sinus infection (86.0 %), while 11.3 % had both sinus and ocular infections, and 2.7 % had sinus and cutaneous infections. Around 21 % (n = 31) of patients deceased after staying in the ICU for a median (range) of 45.0 (10.0–145.0) days. The majority of the patients who deceased had pneumonia patches on computed tomography (CT) (90.3 %) while none of the patients who were discharged had pneumonia patches (<em>p</em> &lt; 0.001). The deceased group had higher rates of pulmonary embolism (93.5 %) compared to the surviving groups (21.8 %). In a multivariate Cox regression analysis, the risk of death was higher in older patients above 60 years old (hazard ratio (95 %CI): 6.7 (1.73–15.81)), increase among patient with history of steroid administration (hazard ratio (95 %CI): <strong>5</strong>.70 (1.<strong>2</strong>3–1<strong>0.9</strong>1)), who had facial cutaneous infection with mucormycosis (hazard ratio (95 %CI): 8.76 (1.78–25.18)), patients with uncontrolled diabetes (hazard ratio (95 %CI): 10.76 (1.78, 65.18)), and total leukocytic count (TLC&gt;10 ×103 mcL) (hazard ratio (95 %CI): 10.03 (3.29–30.61)).</p></div><div><h3>Conclusions</h3><p>Identifying high-risk patients especially old diabetic patients with corticosteroid administration and detecting their deterioration quickly is crucial in reducing post-COVID-19 mucormycosis mortality rates, and these factors must be considered when developing treatment and quarantine strategies.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102523"},"PeriodicalIF":4.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002570/pdfft?md5=c287c13c734d565719d6ac74c1e88b52&pid=1-s2.0-S1876034124002570-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142095072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Germany under the Tinfoil Hat? The associations of the big five personality traits and coronavirus conspiracy beliefs with the intention to get vaccinated 锡箔帽下的德国?五大性格特征和冠状病毒阴谋信念与接种疫苗意向的关联。
IF 4.7 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-08-17 DOI: 10.1016/j.jiph.2024.102519
Stefan Poier , Anna Maria Nikodemska-Wołowik

Background

The governments of democracies worldwide are relying on the active cooperation of their populations to combat COVID-19. Simultaneously, beliefs in conspiracy theories surrounding the pandemic have flourished. The present article examines the effects of the big five personality traits and conspiracy beliefs on the intention to get vaccinated against COVID-19 in Germany.

Methods

This correlational, cross-sectional mediation analysis was conducted using data from a nationwide German household panel (N = 1390).

Results

Openness to experience (β = −.082, p = .004) and neuroticism (β = .112, p < .001) showed direct effects on conspiracy beliefs, while conspiracy beliefs had the strongest effect on vaccination intention (β = −.424, p < .001). Indirect positive effects of openness (β = .035, p = .005) and negative effects of neuroticism (β = −.047, p < .001) on the intention to get vaccinated via conspiracy beliefs were identified, with a mediation in the strict sense only for openness. No direct or total effect of the big five on vaccination intention could be found.

Conclusions

The big five personality traits are associated, although indirectly, with the intention to be vaccinated. Compared with similar studies on the effects of the big five on COVID-19-related outcomes, we found slightly higher proportions of explained variance in conspiracy beliefs and significantly higher explained variance in vaccination intention. In order to increase the willingness to be vaccinated, targeted and nationwide uniform information measures should be provided addressing feelings of security, of not being excluded, and the activation of critical reasoning.

背景:全球民主国家的政府正依靠民众的积极合作来抗击 COVID-19。与此同时,围绕着这一流行病的阴谋论信念也在蓬勃发展。本文研究了五大人格特质和阴谋论信念对德国人接种 COVID-19 疫苗意向的影响:结果:经验开放度(β=5)和阴谋论信念(β=5)对接种 COVID-19 疫苗的意向有显著影响:结果:经验开放性(β = -.082,p = .004)和神经质(β = .112,p 结论:五大人格特质与 COVID-19 相关:五大性格特征与接种疫苗的意愿有间接关系。与有关五大人格特质对 COVID-19 相关结果影响的类似研究相比,我们发现阴谋论信念的解释方差比例略高,而疫苗接种意愿的解释方差则明显更高。为了提高人们接种疫苗的意愿,应该提供有针对性的、全国统一的信息措施,以解决安全感、不被排斥感和批判性推理的激活问题。
{"title":"Germany under the Tinfoil Hat? The associations of the big five personality traits and coronavirus conspiracy beliefs with the intention to get vaccinated","authors":"Stefan Poier ,&nbsp;Anna Maria Nikodemska-Wołowik","doi":"10.1016/j.jiph.2024.102519","DOIUrl":"10.1016/j.jiph.2024.102519","url":null,"abstract":"<div><h3>Background</h3><p>The governments of democracies worldwide are relying on the active cooperation of their populations to combat COVID-19. Simultaneously, beliefs in conspiracy theories surrounding the pandemic have flourished. The present article examines the effects of the big five personality traits and conspiracy beliefs on the intention to get vaccinated against COVID-19 in Germany.</p></div><div><h3>Methods</h3><p>This correlational, cross-sectional mediation analysis was conducted using data from a nationwide German household panel (N = 1390).</p></div><div><h3>Results</h3><p>Openness to experience (β = −.082, p = .004) and neuroticism (β = .112, p &lt; .001) showed direct effects on conspiracy beliefs, while conspiracy beliefs had the strongest effect on vaccination intention (β = −.424, p &lt; .001). Indirect positive effects of openness (β = .035, p = .005) and negative effects of neuroticism (β = −.047, p &lt; .001) on the intention to get vaccinated via conspiracy beliefs were identified, with a mediation in the strict sense only for openness. No direct or total effect of the big five on vaccination intention could be found.</p></div><div><h3>Conclusions</h3><p>The big five personality traits are associated, although indirectly, with the intention to be vaccinated. Compared with similar studies on the effects of the big five on COVID-19-related outcomes, we found slightly higher proportions of explained variance in conspiracy beliefs and significantly higher explained variance in vaccination intention. In order to increase the willingness to be vaccinated, targeted and nationwide uniform information measures should be provided addressing feelings of security, of not being excluded, and the activation of critical reasoning.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 9","pages":"Article 102519"},"PeriodicalIF":4.7,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002533/pdfft?md5=1c64ddc9efb248fb57e6a283ad7197af&pid=1-s2.0-S1876034124002533-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection and Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1